- Home
- VYNE vs UG Comparison
VYNE vs UG Comparison
Compare VYNE & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- UG
- Stock Information
- Founded
- VYNE 2003
- UG 1942
- Country
- VYNE United States
- UG United States
- Employees
- VYNE N/A
- UG N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- UG Package Goods/Cosmetics
- Sector
- VYNE Health Care
- UG Consumer Discretionary
- Exchange
- VYNE Nasdaq
- UG Nasdaq
- Market Cap
- VYNE 35.7M
- UG 36.9M
- IPO Year
- VYNE 2018
- UG N/A
- Fundamental
- Price
- VYNE $0.94
- UG $8.30
- Analyst Decision
- VYNE Strong Buy
- UG
- Analyst Count
- VYNE 2
- UG 0
- Target Price
- VYNE $6.25
- UG N/A
- AVG Volume (30 Days)
- VYNE 259.3K
- UG 6.0K
- Earning Date
- VYNE 05-08-2025
- UG 05-08-2025
- Dividend Yield
- VYNE N/A
- UG 8.43%
- EPS Growth
- VYNE N/A
- UG 4.93
- EPS
- VYNE N/A
- UG 0.63
- Revenue
- VYNE $605,000.00
- UG $11,408,154.00
- Revenue This Year
- VYNE N/A
- UG N/A
- Revenue Next Year
- VYNE N/A
- UG N/A
- P/E Ratio
- VYNE N/A
- UG $13.21
- Revenue Growth
- VYNE 43.03
- UG N/A
- 52 Week Low
- VYNE $0.95
- UG $7.73
- 52 Week High
- VYNE $4.30
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- VYNE 25.37
- UG 48.61
- Support Level
- VYNE $0.96
- UG $8.00
- Resistance Level
- VYNE $1.09
- UG $8.74
- Average True Range (ATR)
- VYNE 0.08
- UG 0.28
- MACD
- VYNE -0.01
- UG 0.03
- Stochastic Oscillator
- VYNE 3.42
- UG 37.04
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.